Nanomedicine News

RSS

Macromolecular Crowding, the New Nanomaterial Stimulus

An article published in the Journal of American Chemical Society presented a new endogenous stimulus, macromolecule crowding, for responsive nanomaterials.

14 Sep 2022

Taking Inspiration from Virus Hijacking to Improve Drug Nanocarriers

An article published in Advanced Science discussed a new strategy inspired by the hijacking strategy of viruses. Here, an endogenous product was hijacked by a drug to assemble into intracellular functional nanoparticles.

13 Sep 2022

Raspberry-Like Nanoadjuvants Help Target Deep Tissue Tumors

Researchers demonstrated a photo-immunometabolic cancer therapy utilizing a second near-infrared window (NIR-II) and programmed raspberry-structured nanoadjuvants.

13 Sep 2022

CRISPR/nCas9 Could Be Used to Treat Mucopolysaccharidosis IV A

An article published in the journal Scientific Reports used CRISPR/nCas9 system on several MPS IVA fibroblasts with GALNS mutations to evaluate their potential in gene therapy.

7 Sep 2022

Seaweed Suggested As Source of Anti-Tuberculosis Nanoparticles

The antibacterial capabilities of a seaweed extract and a unique green synthesis approach for creating well-defined silver seaweed nanoparticles is tested against tuberculosis.

6 Sep 2022

New Bactericidal Mechanism Uses Nanosheet-Based Vacancy Materials

Sulfate-Reducing Bacteria (SRB), an anaerobic bacteria, has long been thought to be the primary factor in metal material corrosion failure.

5 Sep 2022

Nanoparticles Mediate Therapeutic Protein Delivery for Brain Injury Treatment

New research discusses loading BDNF protein into biodegradable porous silicon nanoparticles to deliver the bioactive protein into injured brain tissues.

1 Sep 2022

Nanoparticles Enhance Vaccination Effect of Radiation Therapy

Although combining radiation therapy (RT) with immune checkpoint blockade (ICB) could activate an in situ vaccine effect, RT limits the tumor antigen presentation and cannot overcome suppressive mechanisms in the tumor microenvironment (TME), limiting the vaccine effect.

31 Aug 2022

Using Nanoantibiotics to Counter Antibiotic Resistance Gains US Patent

Over 2.8 million Americans get antibiotic-resistant bacterial infections each year, and about 35,000 of those patients do not make it through their infection, according to the Centers for Disease Control and Prevention.

30 Aug 2022

Novel Nanomedicine Strategy to Treat Ulcerative Colitis

In a recent study, scientists at Georgia State University’s Institute for Biomedical Sciences discovered a potential therapeutic approach for treating ulcerative colitis: oral delivery of lipid nanoparticles that target the colon with nucleic acids.

29 Aug 2022